reports
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
UNH UNITEDHEALTH GROUP INCORPORATED
SEDG SOLAREDGE TECHNOLOGIES INC.
RUN SUNRUN INC.
ROFIN SINAR TECH
RRGB RED ROBIN GOURMET BURGERS INC.
PBYI PUMA BIOTECHNOLOGY INC.
KE KIMBALL ELECTRONICS
GAIA GAIA INC CL A
UEC UNIMIT ENGINEERING
FI FRANK'S INTERNATIONAL NV
FSLR FIRST SOLAR INC.
DK DELEK US HOLDINGS INC
NEON NEONODE INC.
LYFT LYFT
ZETA ZETA GLOBAL HLDGS CORP
ARHS ARHAUS INC
EVLV EVOLV TECHNOLOGIES HLDGS INC
ESEA EUROSEAS LTD
VERB VERB TECHNOLOGY COMPANY INC.
MPLN MULTIPLAN CORPORATION
BKTI BK TECHNOLOGIES CORP
RIGL RIGEL PHARMACEUTICALS INC.
CSIOX CATALYST PERINI STRATEGIC INCOM ORD
SCLX SCILEX HOLDING COMPANY
PubMatic to Participate in Upcoming Financial Conferences
PubMatic to Participate in Upcoming Financial Conferences NO-HEADQUARTERS/REDWOOD CITY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are scheduled to participate at the following upcoming financial conferences: Oppenheimer’s 28th Annual Technology, Internet & Communications Conference on Wednesday, August 13, 2025. Management will participate in a virtual webcasted fire-side chat at 11:35 a.m. ET / 8:35 a.m. PTRosen...
PubMatic Announces Second Quarter 2025 Financial Results
PubMatic Announces Second Quarter 2025 Financial Results Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 34% year-over-year and was 41% of total revenue; CTV revenue grew over 50% year-over-year; Supply Path Optimization represented 55%+ of total activity; and Repurchased 3.5 million shares in Q2 2025, representing 7% of fully diluted shares. NO-HEADQUARTERS/REDWOOD CITY, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain o...
PubMatic Launches AI-Powered Live Sports Marketplace with Real-Time Ga...
PubMatic Launches AI-Powered Live Sports Marketplace with Real-Time Game Moment Curation, FanServ Joins as Premier Partner Capitalizing on an Exponential Increase in Demand, the Marketplace delivers up-to-the-minute inventory access and curation capabilities REDWOOD CITY, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- PubMatic (Nasdaq: PUBM), the independent technology company delivering digital advertising's supply chain of the future, today launched an AI-powered Live Sports Marketplace that enables advertisers to target specific game moments across streaming platforms in real-time. This b...
PubMatic to Announce Second Quarter 2025 Financial Results on August 1...
PubMatic to Announce Second Quarter 2025 Financial Results on August 11, 2025 NO-HEADQUARTERS/REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that it will release its financial results for the second quarter ended June 30, 2025 after market close on Monday, August 11, 2025. On that day, PubMatic will host a webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss the company’s financial results. Webcast Details What: PubMati...
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treat...
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with improved pathologic response. ROCHESTER, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that...
PubMatic to Participate in Upcoming Financial Conferences
PubMatic to Participate in Upcoming Financial Conferences NO-HEADQUARTERS/REDWOOD CITY, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are scheduled to participate and host investor meetings at the following upcoming financial conferences: Jefferies Public Technology Conference on Wednesday May 28, 2025. Management will host one-on-one meetings. Evercore ISI “Nothing But Net” Internet Investors Summit on Wednesday May ...
PubMatic Announces First Quarter 2025 Financial Results; Board of Dire...
PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 20% and was 40% of total revenue; CTV revenue grew over 50% year-over-year; and Supply Path Optimization represented a record 55%+ of total activity NO-HEADQUARTERS/REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today...
PubMatic Unveils AI-Powered Media Buying Platform
PubMatic Unveils AI-Powered Media Buying Platform Buy-Side Technology Enables Transparent Media Buying Across Full Open Internet Inventory NO-HEADQUARTERS/REDWOOD CITY, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- PubMatic, a leader in digital advertising technology, today announced the launch of its upgraded solution suite for buyers, powered by generative AI. PubMatic’s buyer platform streamlines every stage of the media buying process – from audience and inventory discovery and forecasting to curation, activation, and performance optimization. It is the only solution with direct access t...
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s U...
Vaccinex to Report Promising New Clinical Data Revealing Pepinemab’s Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR) Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with durable clinical benefit of immunotherapy in patients with metastatic melanoma. Pepinemab, Semaphorin 4D blocking immunotherapy, also appears to induce the formation of efficient lymphoid structures in “cold” tumors of patients with recurrent and metastatic head and neck cancer. ROCHESTER, N.Y., April ...
PubMatic to Announce First Quarter 2025 Financial Results on May 8, 20...
PubMatic to Announce First Quarter 2025 Financial Results on May 8, 2025 NO-HEADQUARTERS/REDWOOD CITY, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that it will release its financial results for the first quarter ended March 31, 2025 after market close on May 8, 2025. On that day, PubMatic will host a webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss the company’s financial results. Webcast Details What: PubMatic’s First Quart...
PubMatic and Spectrum Reach Partner to Enhance Demand, Efficiency and ...
PubMatic and Spectrum Reach Partner to Enhance Demand, Efficiency and Curation Across CTV Marketplace REDWOOD CITY, Calif. and NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future and Spectrum Reach, the advertising sales business of Charter Communications, today announced a new partnership that will bring increased demand and efficient buying to Spectrum Reach’s advertising inventory while strengthening PubMatic’s curated packages with local news and live sports offered through ...
PubMatic’s Connect Platform for Curation Delivers for Publishers: Driv...
PubMatic’s Connect Platform for Curation Delivers for Publishers: Drives 25%+ Higher eCPMs, Incremental Revenue and Diverse Demand NO-HEADQUARTERS/REDWOOD CITY, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- PubMatic, an independent technology company delivering digital advertising’s supply chain of the future, today announces the success and impact of its platform in driving incremental revenue and efficiency for publishers and advertisers through curated programmatic advertising deals. Curated programmatic deals are emerging as the future of efficient, privacy-first digital marketing. Rec...
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease by blocking astrogliosis and neuroinflammation through the inhibition of SEMA4D, today announced that it has notified the Nasdaq Stock Market (“Nasdaq”) of its decision to delist the Company’s shares of common stock, par value $0.0001 per share (the “Common Stock”), from Nasdaq. Trading in the Commo...
PubMatic Announces Fourth Quarter and Fiscal Year Ended 2024 Financial...
PubMatic Announces Fourth Quarter and Fiscal Year Ended 2024 Financial Results FY Revenue of $291.3 million, up 9% over 2023; Delivered FY 2024 net income of $12.5 million or 4% margin; FY adjusted EBITDA increased 23% over 2023 and was $92.3 million or 32% margin; Revenue in Q4 from CTV more than doubled year over year and represented 20% of total revenue; Supply Path Optimization represented 53% of total activity in 2024; Repurchased 4.3 million shares in 2024, representing 7.9% of fully diluted shares as of December 31, 2024 NO-HEADQUARTERS/REDWOOD CITY, Cali...
PubMatic to Participate in Upcoming Financial Conferences
PubMatic to Participate in Upcoming Financial Conferences NO-HEADQUARTERS/REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are scheduled to participate at the following upcoming financial conferences. The Citizens JMP Technology Conference on Monday March 3, 2025. Management will participate in a webcasted fire-side chat at 1:30 p.m. PT / 4:30 p.m. ETKeyBanc Capital Markets Emerging Technology Summit on Tu...
TCL and PubMatic Join Forces to Drive Demand and Efficiency in Streami...
TCL and PubMatic Join Forces to Drive Demand and Efficiency in Streaming Live Sports Advertising NO-HEADQUARTERS/REDWOOD CITY, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- TCL, a leading global television brand and PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced a new partnership designed to enhance programmatic advertising for live sports. This new partnership will connect TCL’s premium programmatic streaming inventory, including NFL Channel and CBS Sports, with PubMatic’s integrated platform to drive de...
PubMatic to Announce Fourth Quarter and Full Year 2024 Financial Resul...
PubMatic to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 NO-HEADQUARTERS/REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that it will release its financial results for the quarter and fiscal year ended December 31, 2024 after market close on February 27, 2025. On that day, PubMatic will host a webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss the company’s financial results. Webcast D...
PubMatic’s Activate Achieves Significant Industry Adoption: 100% of “B...
PubMatic’s Activate Achieves Significant Industry Adoption: 100% of “Big Six” Advertising Agencies Now Leverage the Platform for Efficiency and Growth NO-HEADQUARTERS/REDWOOD CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- PubMatic, an independent technology company delivering digital advertising’s supply chain of the future, today announces the rapid adoption and market share growth of its innovative media activation platform, . In today's dynamic digital environment, advertisers face growing challenges: navigating complex supply chains, optimizing campaigns across a fragmented landscap...
Vaccinex Announces Receipt of Delisting Notification from Nasdaq
Vaccinex Announces Receipt of Delisting Notification from Nasdaq ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease by blocking astrogliosis and neuroinflammation through the inhibition of SEMA4D, today announced that on December 16, 2024, the Company received written notice (the “Notice”) from the Office of General Counsel of The Nasdaq Stock Market (“Nasdaq”) indicating that the Nasdaq Hearings Panel has determined...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.